Ratings Don’t Lie: Analysts at Macquarie Maintained their Neutral rating for Mediclinic International (LON:MDC) with GBX 763.00 Target

November 23, 2016 - By Darrin Black

Mediclinic International (LON:MDC) Rating

In analysts report made public on Wednesday, 23 November, Mediclinic International (LON:MDC) stock had its Neutral Rating reconfirmed by expert analysts at Macquarie. They currently have a GBX 763.00 TP on firm. Macquarie’s target means a potential upside of 4.23% from the company’s previous stock close.

Mediclinic International PLC (LON:MDC) Ratings Coverage

Out of 10 analysts covering Mediclinic International (LON:MDC), 3 rate it a “Buy”, 1 “Sell”, while 6 “Hold”. This means 30% are positive. GBX 1170 is the highest target while GBX 745 is the lowest. The GBX 946.60 average target is 30.12% above today’s (GBX 727.5) stock price. Mediclinic International has been the topic of 18 analyst reports since February 18, 2016 according to StockzIntelligence Inc. The rating was maintained by Investec with “Buy” on Monday, March 14. Citigroup downgraded the stock to “Neutral” rating in Monday, September 12 report. The firm earned “Neutral” rating on Tuesday, August 23 by JP Morgan. The stock of Mediclinic International PLC (LON:MDC) earned “Neutral” rating by Citigroup on Tuesday, May 24. On Friday, November 11 the stock rating was maintained by Credit Suisse with “Outperform”. The stock of Mediclinic International PLC (LON:MDC) earned “Buy” rating by UBS on Monday, November 21. The stock of Mediclinic International PLC (LON:MDC) earned “Buy” rating by Citigroup on Tuesday, June 28. The stock of Mediclinic International PLC (LON:MDC) earned “Hold” rating by Jefferies on Wednesday, September 28. Macquarie Research maintained the shares of MDC in a report on Friday, May 27 with “Neutral” rating. The firm has “Hold” rating by Jefferies given on Tuesday, July 26.

About 492,995 shares traded hands. Mediclinic International PLC (LON:MDC) has declined 19.73% since April 26, 2016 and is downtrending. It has underperformed by 25.05% the S&P500.

Insitutional Activity: The institutional sentiment increased to 1.22 in 2016 Q2. Its up 0.39, from 0.83 in 2016Q1. The ratio improved, as 26 funds sold all Mediclinic International PLC shares owned while 62 reduced positions. 21 funds bought stakes while 52 increased positions. They now own 38.01 million shares or 0.55% more from 37.80 million shares in 2016Q1.

Bancorporation Of Mellon has 0.01% invested in the company for 760,129 shares. Oppenheimer And Company accumulated 0.02% or 32,676 shares. Goldman Sachs Group Inc Inc last reported 0% of its portfolio in the stock. Moreover, Alliancebernstein L P has 0% invested in Mediclinic International PLC (LON:MDC) for 87,022 shares. Pacifica Capital Ltd Liability Com accumulated 4.23% or 329,140 shares. Finemark State Bank accumulated 500 shares or 0% of the stock. Louisiana State Employees Retirement Sys accumulated 17,400 shares or 0.02% of the stock. Old Mutual Invsts (Uk) Ltd holds 0.06% or 139,105 shares in its portfolio. Etrade Cap Lc holds 0.06% or 43,739 shares in its portfolio. Manufacturers Life Ins Co The last reported 26,284 shares in the company. Wells Fargo And Mn accumulated 1.09M shares or 0.01% of the stock. Mgmt Of Virginia Limited accumulated 1.69% or 271,049 shares. Texas Permanent School Fund reported 29,979 shares or 0.01% of all its holdings. Fmr Ltd Llc last reported 0.01% of its portfolio in the stock. Capital holds 0.01% of its portfolio in Mediclinic International PLC (LON:MDC) for 790,000 shares.

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The company has a market cap of 5.36 billion GBP. The Firm operates as an international private healthcare provider. It has a 26.6 P/E ratio. The Company’s divisions include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate.

According to Zacks Investment Research, “M.D.C. HOLDINGS, INC. is engaged in the construction, sale and related financing of residential housing and the acquisition and development of land for use in its homebuilding activities and sale to others, in the Denver, Phoenix, Maryland, Virginia, mid Atlantic region, Las Vegas, Dallas, California metropolitan areas. They are also is involved in real estate brokerage, property management, condominium conversions and fee construction of apartment and commercial buildings.”

MDC Company Profile

M.D.C. Holdings, Inc., incorporated on May 17, 1985, is engaged in two primary operations, including homebuilding and financial services. The Company’s homebuilding activities consist of subsidiary companies that purchases finished lots or develop lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the name Richmond American Homes. The Company’s homebuilding activities consists of various homebuilding divisions that the Company considers to be its operating divisions. The Company’s operating divisions include West (include operating divisions located in Arizona, California, Nevada and Washington); Mountain (include operating divisions located in Colorado and Utah), and East (include operating divisions located in Virginia, Florida and Maryland, which include Pennsylvania, and New Jersey).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>